Question 1

What specific symptoms of agitation does ITI-007 aim to improve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease clinical trial (NCT02817906). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ITI-007 compare to other treatments I might be considering?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease clinical trial (NCT02817906). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with ITI-007?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease clinical trial (NCT02817906). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease clinical trial (NCT02817906). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease clinical trial (NCT02817906). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there a chance I might receive a placebo instead of the active treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease clinical trial (NCT02817906). Contact the study team or your healthcare provider for specific answers.

What this study is about